Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2019Journal of Clinical MicrobiologyOpen Access

New Subgenotyping and Consensus Real-Time Reverse Transcription-PCR Assays for Hepatitis A Outbreak Surveillance

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Hepatitis A outbreak surveillance requires rapid and accurate molecular diagnostic tools for HAV RNA detection, subgenotype identification, and sequence-based genotyping.

Does a new triplex rRT-PCR assay accurately detect and discriminate hepatitis A virus subgenotypes compared to standard methods in serum and plasma specimens?

Population

Serum and plasma specimens collected during unrelated HAV outbreaks in California and Michigan

Comparison

New triplex and singleplex rRT-PCR assays vs nested RT-PCR genotyping and ISO 15216-1 rRT-PCR

Design

Assay development and validation study

Authors

WPWilliam S. ProbertCalifornia Department of Public HealthJHJill K. HackerCalifornia Health and Human Services Agency

Discussion

Loading...

Member takes

Overview

May aid HAV outbreak surveillance; leaves open prospective validation before routine diagnostic adoption.

Structured PICO

Does a new triplex rRT-PCR assay accurately detect and discriminate hepatitis A virus subgenotypes compared to standard methods in serum and plasma specimens?

P
Population
Serum and plasma specimens collected during unrelated outbreaks of hepatitis A virus (HAV) in California and Michigan
I
Intervention
Triplex real-time, reverse transcription-PCR (triplex rRT-PCR) assay for HAV subgenotypes IA, IB, and IIIA and a singleplex rRT-PCR assay for all HAV genotypes
C
Comparator
Nested RT-PCR genotyping assay and the ISO 15216-1 rRT-PCR method
O
Outcome
Accuracy, sensitivity, and specificity of the new assayssurrogate

The newly developed triplex and singleplex rRT-PCR assays provide highly accurate (>97%) and rapid detection and subgenotyping of hepatitis A virus, which can enhance public health outbreak surveillance.

Cite This Study

Probert et al. (2019) studied this question.

synapsesocial.com/papers/6a708f6a8031ec7bb1dc6d38https://doi.org/10.1128/jcm.00500-19
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development, Evaluation, and Standardization of a Real-Time TaqMan Reverse Transcription-PCR Assay for Quantification of Hepatitis A Virus in Clinical and Shellfish Samples2006 · 472 citations
  2. 2The Drift in Molecular Testing for Influenza: Mutations Affecting Assay Performance2018 · 46 citations
  3. 3Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction2012 · 6,406 citations
  4. 4Epidemiology and Transmission of Hepatitis A Virus and Hepatitis E Virus Infections in the United States2018 · 52 citations
  5. 5Immunoglobulin M for Acute Infection: True or False?2016 · 113 citations